Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, ...

Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...

A new editorial was published in Oncotarget's Volume 15 on December 24, 2024, titled "Pitfalls and perils from FDA-approved germ-line cancer predisposition tests." ...

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase ...

These diseases all involve the development of germ cells, the structure and function of reproductive ... expression caused by abnormal development of reproductive organs, gonadal (ovarian or ...

As part of the partnership, the charity also delivered its life-saving awareness talk around testicular and ovarian cancer to staff ... to raise awareness of germ cell cancers and also provide ...

Doctors biopsied it to understand the type of cancer it was and discovered it was something called a germ cell tumor, a cancer that forms from nascent reproductive cells. Pastuovic said his tumor ...

Accumulating evidence indicates that epigenetic modifiers have key roles in genome-wide reprogramming and activation and repression of specific genes during mammalian germ-cell development.

Atypical teratoid rhabdoid tumors (AT/RT) were treated with “carboplatin + pirarubicin + cyclophosphamide” or “ifosfamide + carboplatin + etoposide”. Germinomas were typically treated with ...

To address this gap, researchers analyzed gene expression within individual tumor cells. This study reports the molecular features and interactions of tumor and immune cells associated with two ...